3 research outputs found

    New Surgical Technologies Could Facilitate Surgical Hemostasis in Hemophilic Patients

    Get PDF
    BACKGROUND: ItÒ€ℒs assumed that surgery in haemophilia can be accomplished these days safely.AIM: The aim of this study was to investigate the influence of new surgical technologies in the perioperative management and outcome of surgical procedures in haemophiliacs.METHODS: Two patients with mild haemophilia A underwent surgery (laparoscopic appendectomy and inguinal hernia repair). In both patients, the replacement therapy, with factor VIII, started 30 min before surgery. We used the available surgical technologies and techniques with a proven value in the best clinical practice, to achieve proper and permanent hemostasis. Postoperatively, the replacement therapy and thromboembolic prophylaxis was continued according to the international guidelines for the management of haemophilia.RESULTS: The operative and post-operative periods were uneventful. No significant differences were found in the operation time in our hemophilic patients versus non-hemophilic patients. Significant differences related to the hospital stay duration were found in both patients compared with controls, due to the necessary replacement therapy.CONCLUSION: With new surgical technologies, proper and permanent hemostasis can be achieved, without prolonging the operation time

    Multidisciplinary approach to management of hypofibrinogenaemia in pregnancy: A case report

    Get PDF
    Inherited fibrinogen disorders introduce risk for recurrent abortions, sub-chorionic haematoma, placental abruption and postpartum haemorrhage. This is a case report of a successful pregnancy outcome in a 37-year old woman with hypofibrinogenaemia. She was referred to a coagulation test in the first trimester because of history of preeclampsia and HELLP syndrome in previous pregnancy. Hypofibrinogenaemia was diagnosed with fibrinogen level of 0.7 g/L. During the pregnancy she was regularly monitored for fibrinogen levels and multiple cryoprecipitate concentrates were given. She delivered at 39th gestation week, with elective caesarean section under general anaesthesia. There was one episode of postpartum haemorrhage treated with 2 units of red blood cells, repeated infusions of cryoprecipitate to obtain the level of fibrinogen of 2 g/L. She was discharged on the 6th postpartum day in a good condition. In these disorders levels of fibrinogen should be higher than 1 g/L during pregnancy or 2 g/L in case of caesarean section for successful prenatal and peripartal management

    AΡΠΎΡ†ΠΈΡ˜Π°Ρ†ΠΈΡ˜Π° Π½Π° ΠΏΠ»Π°Π·ΠΌΠ° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈΡ‚Π΅ со стадиумитС Π½Π° Ρ†Ρ€Π½ΠΎΠ΄Ρ€ΠΎΠ±Π½Π° Ρ†ΠΈΡ€ΠΎΠ·Π° ΠΈ Π½Π΅Ρ˜Π·ΠΈΠ½ΠΈΡ‚Π΅ ΠΊΠΎΠΌΠΏΠ»ΠΈΠΊΠ°Ρ†ΠΈΠΈ

    No full text
    Aim of the study: To investigate plasma D-dimer levels in correlation with Child-Pugh-Turcotte (CTP) and Model for End-Stage Liver Disease (MELD) scores in patients with liver cirrhosis (LC) of different severity, as well as the correlation with LC-associated clinical, biochemical parameters and complications. Material and methods: Fifty patients with LC were divided in three groups according to LC severity using the CTP Score (CTP-A, CTP-B, CTP-C).Β  The levels of D-dimer were measured in sodium-citrate plasma on Siemens, BCS XP Blood Coagulometer. Kruskal-Wallis test was used to compare D-dimer levels between the groups. Mann-Whitney U test was used to evaluate the difference of D-dimer levels in groups with different MELD score, and to evaluate the difference in D-dimer levels in patients with presence or absence of ascites and the difference of D-dimer levels in patients with or without spontaneous bacterial peritonitis (SBP). Pearson’s coefficient of correlation was used to evaluate the correlation between D-dimer levels with MELD score and the correlation between D-dimer levels and the concentration of LC-associated biochemical, clinical parameters and complications. Results: D-dimer levels increased with severity of the disease as assessed with CTP and MELD scores, with a statistically significant difference between the groups (p=.0000 and p=.0001, respectively). Group CTP-C demonstrated the highest D-dimer levels, followed by groups B and A. Patients with SBP had significantly higher levels of D-dimers than patients without SBP (p=.0006). A significant positive correlation between D-dimers and CTP and MELD score was detected (r= 0.74 and r=0.44, respectively; p<.001). A correlation between D-dimer levels and several biochemical parameters characterizing progressive liver dysfunction was observed. From all investigated biochemical parameters, the highest significant correlation was detected between D-dimer levels and the concentration of serum albumin (r= -0.65, p<.001). Conclusions: Plasma D-dimer levels are tightly correlated with the degree of liver dysfunction and LC-associated complications. Therefore, D-dimer levels could be utilized as a prognostic stratification marker and adjunctive diagnostic marker in LC-associated complications.Β Π¦Π΅Π» Π½Π° ΡΡ‚ΡƒΠ΄ΠΈΡ˜Π°Ρ‚Π°: Π”Π° сС испита Π½ΠΈΠ²ΠΎΡ‚ΠΎ Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈ Π²ΠΎ ΠΏΠ»Π°Π·ΠΌΠ° Π²ΠΎ ΠΊΠΎΡ€Π΅Π»Π°Ρ†ΠΈΡ˜Π° со ΠΊΠ»ΠΈΠ½ΠΈΡ‡ΠΊΠΈΡ‚Π΅ скорови: Child-Pugh-Turcotte (CTP) ΠΈ Model for End-Stage Liver Disease (MELD) кај ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈ со Ρ†Ρ€Π½ΠΎΠ΄Ρ€ΠΎΠ±Π½Π° Ρ†ΠΈΡ€ΠΎΠ·Π° со Ρ€Π°Π·Π»ΠΈΡ‡Π½Π° Ρ‚Π΅ΠΆΠΈΠ½Π°, ΠΊΠ°ΠΊΠΎ ΠΈ Π½ΠΈΠ²Π½Π° ΠΊΠΎΡ€Π΅Π»Π°Ρ†ΠΈΡ˜Π° со ΠΊΠ»ΠΈΠ½ΠΈΡ‡ΠΊΠΈ, биохСмиски ΠΏΠ°Ρ€Π°ΠΌΠ΅Ρ‚Ρ€ΠΈ ΠΈ ΠΊΠΎΠΌΠΏΠ»ΠΈΠΊΠ°Ρ†ΠΈΠΈ ΠΏΠΎΠ²Ρ€Π·Π°Π½ΠΈ со Ρ†Ρ€Π½ΠΎΠ΄Ρ€ΠΎΠ±Π½Π° Ρ†ΠΈΡ€ΠΎΠ·Π°. ΠœΠ°Ρ‚Π΅Ρ€ΠΈΡ˜Π°Π»ΠΈ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈ:Β  Π’ΠΊΡƒΠΏΠ½ΠΎ 50 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈ со Ρ†ΠΈΡ€ΠΎΠ·Π° Π½Π° Ρ†Ρ€Π½ Π΄Ρ€ΠΎΠ± Π±Π΅Π° ΠΏΠΎΠ΄Π΅Π»Π΅Π½ΠΈ Π²ΠΎ Ρ‚Ρ€ΠΈ Π³Ρ€ΡƒΠΏΠΈ спорСд Ρ‚Π΅ΠΆΠΈΠ½Π°Ρ‚Π° Π½Π° Ρ†ΠΈΡ€ΠΎΠ·Π° Π½Π° Ρ†Ρ€Π½ΠΈΠΎΡ‚ Π΄Ρ€ΠΎΠ± Π²Ρ€Π· основа Π½Π° CTP Score (CTP-A, CTP-Π‘, CTP-C). ΠšΠΎΠ½Ρ†Π΅Π½Ρ‚Ρ€Π°Ρ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈΡ‚Π΅ бСшС ΠΎΠ΄Ρ€Π΅Π΄Π΅Π½Π° Π²ΠΎ ΠΏΠ»Π°Π·ΠΌΠ° со Π½Π°Ρ‚Ρ€ΠΈΡƒΠΌ Ρ†ΠΈΡ‚Ρ€Π°Ρ‚ ΠΊΠΎΡ€ΠΈΡΡ‚Π΅Ρ˜ΡœΠΈ Π³ΠΎ Siemens, BCSXP ΠΊΡ€Π²Π½ΠΈΠΎΡ‚ ΠΊΠΎΠ°Π³ΡƒΠ»ΠΎΠΌΠ΅Ρ‚Π°Ρ€. Kruskal-Wallis тСстот бСшС користСн Π·Π° Π΄Π° сС спорСдат Π½ΠΈΠ²ΠΎΠ°Ρ‚Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈ ΠΏΠΎΠΌΠ΅Ρ“Ρƒ CTP Π³Ρ€ΡƒΠΏΠΈΡ‚Π΅. Mann-Whitney U тСстот бСшС Π½Π°ΠΏΡ€Π°Π²Π΅Π½ Π·Π° Π΄Π° сС ΠΎΠ΄Ρ€Π΅Π΄ΠΈ Ρ€Π°Π·Π»ΠΈΠΊΠ°Ρ‚Π° Π²ΠΎ Π½ΠΈΠ²ΠΎΠ°Ρ‚Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈΡ‚Π΅ ΠΏΠΎΠΌΠ΅Ρ“Ρƒ Π³Ρ€ΡƒΠΏΠΈΡ‚Π΅ со Ρ€Π°Π·Π»ΠΈΡ‡Π΅Π½ MELD скор, ΠΈ Π·Π° Π΄Π° сС ΠΎΡ†Π΅Π½ΠΈ Ρ€Π°Π·Π»ΠΈΠΊΠ°Ρ‚Π° Π²ΠΎ Π½ΠΈΠ²ΠΎΠ°Ρ‚Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈΡ‚Π΅ кај ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈ со присуство ΠΈΠ»ΠΈ отсуство Π½Π° асцит ΠΈ Ρ€Π°Π·Π»ΠΈΠΊΠ°Ρ‚Π° Π²ΠΎ Π½ΠΈΠ²ΠΎΠ°Ρ‚Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈΡ‚Π΅ кај ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈ со ΠΈΠ»ΠΈ Π±Π΅Π· спонтан бактСриски пСритонитис (SBP). Pearson-ΠΎΠ²ΠΈΠΎΡ‚ ΠΊΠΎΠ΅Ρ„ΠΈΡ†ΠΈΠ΅Π½Ρ‚ Π½Π° ΠΊΠΎΡ€Π΅Π»Π°Ρ†ΠΈΡ˜Π° бСшС користСн Π·Π° Π΄Π° сС ΠΎΡ†Π΅Π½ΠΈ ΠΊΠΎΡ€Π΅Π»Π°Ρ†ΠΈΡ˜Π°Ρ‚Π° ΠΏΠΎΠΌΠ΅Ρ“Ρƒ Π½ΠΈΠ²ΠΎΠ°Ρ‚Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈ со MELD скорот ΠΈ ΠΊΠΎΡ€Π΅Π»Π°Ρ†ΠΈΡ˜Π°Ρ‚Π° ΠΏΠΎΠΌΠ΅Ρ“Ρƒ Π½ΠΈΠ²ΠΎΠ°Ρ‚Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈ ΠΈ ΠΊΠΎΠ½Ρ†Π΅Π½Ρ‚Ρ€Π°Ρ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° биохСмиски, ΠΊΠ»ΠΈΠ½ΠΈΡ‡ΠΊΠΈ ΠΏΠ°Ρ€Π°ΠΌΠ΅Ρ‚Ρ€ΠΈ ΠΈ ΠΊΠΎΠΌΠΏΠ»ΠΈΠΊΠ°Ρ†ΠΈΠΈ ΠΏΠΎΠ²Ρ€Π·Π°Π½ΠΈ со Ρ†Ρ€Π½ΠΎΠ΄Ρ€ΠΎΠ±Π½Π° Ρ†ΠΈΡ€ΠΎΠ·Π°. Π Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ΠΈ: ΠšΠΎΠ½Ρ†Π΅Π½Ρ‚Ρ€Π°Ρ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈΡ‚Π΅ сС Π·Π³ΠΎΠ»Π΅ΠΌΠΈ со Ρ‚Π΅ΠΆΠΈΠ½Π°Ρ‚Π° Π½Π° болСста ΠΏΡ€ΠΎΡ†Π΅Π½Π΅Ρ‚Π° со CTP ΠΈ MELDскорот со статистички Π·Π½Π°Ρ‡Π°Ρ˜Π½Π° Ρ€Π°Π·Π»ΠΈΠΊΠ° ΠΏΠΎΠΌΠ΅Ρ“Ρƒ Π³Ρ€ΡƒΠΏΠΈΡ‚Π΅ (p=,0000 ΠΈ p=,0001, соодвСтно). Π“Ρ€ΡƒΠΏΠ°Ρ‚Π° CTP-C ΠΏΠΎΠΊΠ°ΠΆΠ° највисока ΠΊΠΎΠ½Ρ†Π΅Π½Ρ‚Ρ€Π°Ρ†ΠΈΡ˜Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈ, ΠΏΠΎ ΡˆΡ‚ΠΎ слСдуваа Π³Ρ€ΡƒΠΏΠΈΡ‚Π΅ Π‘ ΠΈ А. ΠŸΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈΡ‚Π΅ со SBP ΠΈΠΌΠ°Π° Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»Π½ΠΎ повисока ΠΊΠΎΠ½Ρ†Π΅Π½Ρ‚Ρ€Π°Ρ†ΠΈΡ˜Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈ Π²ΠΎ спорСдба со ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΈΡ‚Π΅ Π±Π΅Π· SBP (p= ,0006). Π‘Π΅ΡˆΠ΅ ΡƒΡ‚Π²Ρ€Π΄Π΅Π½Π° Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»Π½Π° ΠΏΠΎΠ·ΠΈΡ‚ΠΈΠ²Π½Π° ΠΊΠΎΡ€Π΅Π»Π°Ρ†ΠΈΡ˜Π° ΠΏΠΎΠΌΠ΅Ρ“Ρƒ Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈΡ‚Π΅ ΠΈ CTP ΠΈ MELD скорот (ΠΊΠΎΠ΅Ρ„ΠΈΡ†ΠΈΠ΅Π½Ρ‚ Π½Π° ΠΊΠΎΡ€Π΅Π»Π°Ρ†ΠΈΡ˜Π° r= 0,74 ΠΈ r= 0,44, соодвСтно; p< ,001). Π”ΠΎΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»Π½ΠΎ, Ρ€Π΅Π·ΡƒΠ»Ρ‚Π°Ρ‚ΠΈΡ‚Π΅ ΠΏΠΎΠΊΠ°ΠΆΠ°Π° Π΄Π΅ΠΊΠ° постои поврзаност ΠΌΠ΅Ρ“Ρƒ ΠΏΠ»Π°Π·ΠΌΠ° ΠΊΠΎΠ½Ρ†Π΅Π½Ρ‚Ρ€Π°Ρ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈΡ‚Π΅ со ΠΊΠ»ΠΈΠ½ΠΈΡ‡ΠΊΠΈΡ‚Π΅ ΠΈ биохСмиски ΠΏΠ°Ρ€Π°ΠΌΠ΅Ρ‚Ρ€ΠΈ ΠΊΠΎΠΈ ΠΊΠ°Ρ€Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ·ΠΈΡ€Π°Π°Ρ‚ прогрСсивна Π΄ΠΈΡΡ„ΡƒΠ½ΠΊΡ†ΠΈΡ˜Π° Π½Π° Ρ†Ρ€Π½ΠΈΠΎΡ‚Π΄Ρ€ΠΎΠ±. Од ситС испитувани биохСмиски ΠΏΠ°Ρ€Π°ΠΌΠ΅Ρ‚Ρ€ΠΈ, највисока статистички Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»Π½Π° ΠΊΠΎΡ€Π΅Π»Π°Ρ†ΠΈΡ˜Π° бСшС ΡƒΡ‚Π²Ρ€Π΄Π΅Π½Π° ΠΌΠ΅Ρ“Ρƒ Π½ΠΈΠ²ΠΎΠ°Ρ‚Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈΡ‚Π΅ ΠΈ ΠΊΠΎΠ½Ρ†Π΅Π½Ρ‚Ρ€Π°Ρ†ΠΈΡ˜Π°Ρ‚Π° Π½Π° сСрумскитС Π°Π»Π±ΡƒΠΌΠΈΠ½ΠΈ (r = - 0,65, p< 0,001). Π—Π°ΠΊΠ»ΡƒΡ‡ΠΎΠΊ: ΠŸΠ»Π°Π·ΠΌΠ°Ρ‚ΡΠΊΠ°Ρ‚Π° ΠΊΠΎΠ½Ρ†Π΅Π½Ρ‚Ρ€Π°Ρ†ΠΈΡ˜Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈΡ‚Π΅ Π΅ тСсно ΠΏΠΎΠ²Ρ€Π·Π°Π½Π° со стСпСнот Π½Π° Π΄ΠΈΡΡ„ΡƒΠ½ΠΊΡ†ΠΈΡ˜Π° Π½Π° Ρ†Ρ€Π½ΠΈΠΎΡ‚Π΄Ρ€ΠΎΠ± ΠΈ ΠΊΠΎΠΌΠΏΠ»ΠΈΠΊΠ°Ρ†ΠΈΠΈΡ‚Π΅ ΠΏΠΎΠ²Ρ€Π·Π°Π½ΠΈ со Ρ†ΠΈΡ€ΠΎΠ·Π° Π½Π° Ρ†Ρ€Π½ Π΄Ρ€ΠΎΠ±. Π—Π°Ρ‚ΠΎΠ°, Π½ΠΈΠ²ΠΎΠ°Ρ‚Π° Π½Π° Π”-Π΄ΠΈΠΌΠ΅Ρ€ΠΈΡ‚Π΅ ΠΌΠΎΠΆΠ΅ Π΄Π° сС користат ΠΊΠ°ΠΊΠΎ прогностички ΠΌΠ°Ρ€ΠΊΠ΅Ρ€ Π·Π° ΡΡ‚Ρ€Π°Ρ‚ΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΡ˜Π° ΠΈ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»Π΅Π½ Π΄ΠΈΡ˜Π°Π³Π½ΠΎΡΡ‚ΠΈΡ‡ΠΊΠΈ ΠΌΠ°Ρ€ΠΊΠ΅Ρ€ Π²ΠΎ ΠΊΠΎΠΌΠΏΠ»ΠΈΠΊΠ°Ρ†ΠΈΠΈΡ‚Π΅ ΠΏΠΎΠ²Ρ€Π·Π°Π½ΠΈ со Ρ†ΠΈΡ€ΠΎΠ·Π° Π½Π° Ρ†Ρ€Π½ Π΄Ρ€ΠΎΠ±
    corecore